Pages that link to "Q35689228"
Jump to navigation
Jump to search
The following pages link to Evidence for an intramacrophage growth phase of Mycobacterium ulcerans (Q35689228):
Displaying 50 items.
- First cultivation and characterization of mycobacterium ulcerans from the environment (Q21092307) (← links)
- Bacterial Toxins as Pathogen Weapons Against Phagocytes (Q26766446) (← links)
- Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin (Q28469338) (← links)
- Detection of Mycolactone A/B in Mycobacterium ulcerans-Infected Human Tissue (Q28472261) (← links)
- Regulation of mycolactone, the Mycobacterium ulcerans toxin, depends on nutrient source (Q28535119) (← links)
- Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice (Q28538249) (← links)
- Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease (Q28538259) (← links)
- Aquatic insects and Mycobacterium ulcerans: an association relevant to Buruli ulcer control? (Q33275814) (← links)
- Improved protective efficacy of a species-specific DNA vaccine encoding mycolyl-transferase Ag85A from Mycobacterium ulcerans by homologous protein boosting (Q33324374) (← links)
- Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer (Q33511900) (← links)
- BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse (Q33851427) (← links)
- Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection? (Q33988898) (← links)
- Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen (Q34016179) (← links)
- Pharmacokinetics of rifampin and clarithromycin in patients treated for Mycobacterium ulcerans infection. (Q34108761) (← links)
- Clinical efficacy of combination of rifampin and streptomycin for treatment of Mycobacterium ulcerans disease. (Q34108789) (← links)
- Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination (Q34193844) (← links)
- Buruli ulcer (Q34229628) (← links)
- Amoebae as Potential Environmental Hosts for Mycobacterium ulcerans and Other Mycobacteria, but Doubtful Actors in Buruli Ulcer Epidemiology (Q34374912) (← links)
- Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression (Q34484489) (← links)
- Corticosteroid-induced immunosuppression ultimately does not compromise the efficacy of antibiotherapy in murine Mycobacterium ulcerans infection (Q34500901) (← links)
- Buruli ulcer (Mycobacterium ulcerans infection). (Q34863767) (← links)
- Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease (Q34630531) (← links)
- Structure-activity relationship studies on the macrolide exotoxin mycolactone of Mycobacterium ulcerans (Q34654293) (← links)
- Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model (Q34702499) (← links)
- Mycobacterium liflandii outbreak in a research colony of Xenopus (Silurana) tropicalis frogs (Q35206412) (← links)
- Chemotherapy-associated changes of histopathological features of Mycobacterium ulcerans lesions in a Buruli ulcer mouse model (Q35689285) (← links)
- Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease. (Q35746584) (← links)
- Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection (Q35790836) (← links)
- Spontaneous Healing of Mycobacterium ulcerans Lesions in the Guinea Pig Model (Q35857386) (← links)
- Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer. (Q35915755) (← links)
- Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice (Q35919532) (← links)
- Challenges associated with management of buruli ulcer/human immunodeficiency virus coinfection in a treatment center in Ghana: A case series study (Q35933855) (← links)
- Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection (Q38639741) (← links)
- Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates. (Q36205512) (← links)
- Dynamics of the cytokine response to Mycobacterium ulcerans during antibiotic treatment for M. ulcerans disease (Buruli ulcer) in humans (Q37051036) (← links)
- Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans (Q37349850) (← links)
- When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system (Q37669333) (← links)
- An Optimized Method for Extracting Bacterial RNA from Mouse Skin Tissue Colonized by Mycobacterium ulcerans (Q37719029) (← links)
- Bacterial proteases from the intracellular vacuole niche; protease conservation and adaptation for pathogenic advantage (Q37733692) (← links)
- Neutrophils: Cinderella of innate immune system (Q37786691) (← links)
- History, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease). (Q38157768) (← links)
- Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer (Q38180777) (← links)
- Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease. (Q38634493) (← links)
- Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria (Q39413440) (← links)
- Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms (Q42372966) (← links)
- Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans (Q46241939) (← links)
- Localised Mycobacterium ulcerans infection in a cat in Australia (Q46582749) (← links)
- Buruli ulcer - beyond the skin, impact on skeletal muscle (Q46809372) (← links)
- Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans (Q57203196) (← links)
- Buruli Ulcer in Sub-Saharan Africa (Q59356163) (← links)